about
Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical ImplicationsReductions in cardiovascular risk after bariatric surgeryThe neurohormonal regulation of energy intake in relation to bariatric surgery for obesityCardiovascular risk assessment--from individual risk prediction to estimation of global risk and change in risk in the population.Cardiovascular benefits of bariatric surgery in morbidly obese patients.Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish obese subjects trial.Dynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period.Benchmarking best practices in weight loss surgery.Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients.Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study.Effect of bariatric surgery on cardiometabolic risk in elderly patients: A population-based studyS.O.S.Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signalingTrends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation.Bariatric Surgery in Type 1 Diabetes Mellitus: A Systematic Review.Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience.All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes.Mesenchymal stem cells in obesity: insights for translational applications.Vascular risk in obesity: Facts, misconceptions and the unknown.Elective surgery to save my life: rethinking the "choice" in bariatric surgery.Not 'Taking the Easy Way Out': Reframing Bariatric Surgery from Low-effort Weight Loss to Hard Work.Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass.High blood pressure and obesity increase the risk of abnormal glucose tolerance in young adult african americans.Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits?Changes in myocardial mechanics in patients with obesity following major weight loss after bariatric surgery.Measuring health-related quality of life in non-complicated diabetes patients may be an effective parameter to assess patients at risk of a more serious disease course: a cross-sectional study of two diabetes outpatient groups.Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).Heart rate variability and cardio-respiratory coupling during sleep in patients prior to bariatric surgery.Laparoscopic Roux-En-Y Gastric Bypass Improves Lipid Profile and Decreases Cardiovascular Risk: a 5-Year Longitudinal Cohort Study of 1048 Patients.Risk perception of obesity and bariatric surgery in patients seeking treatment for obesity.
P2860
Q26745520-DF5D225E-25BD-4A38-A9FE-EEF78C51EC08Q26830659-C1B157B1-93E1-4FCA-803B-F46543C960B3Q30388925-A1061734-FD95-4BAC-8102-BA857B9D56D9Q33586716-7668D88E-9185-4E6E-82CA-7A19B30BFE09Q33829180-DA8E4044-41B5-4413-A959-87536DDEC5BCQ33926605-276EE0D3-E320-4DFA-AD0E-56131D22EA7FQ34097365-72D58F9B-5308-4B1D-95BB-A7C7504C1419Q34791792-1753A311-3CB6-489B-9BA1-E0BF0DB6DDD4Q35099949-75F85227-2B79-4FFD-9769-2A5835319D34Q36084126-0DE02016-77AA-44E6-A644-88A007E0884DQ36291187-99ABBD87-4C73-4320-B8E0-B3AC419AAA0EQ36327719-B5B19633-6997-442A-A336-B59A55DFA9AFQ36426804-A8C0AA87-5258-4416-B000-BE84B6368FAEQ37136352-E9A651C6-8542-4B9B-80FF-4A24E3D145D0Q37426315-6C5D9CED-D19A-42D5-8DC0-F86FA407B41DQ37697736-86BDBAA6-63AC-4A1C-8A98-804F1DC9CCAAQ38038499-A66DFA32-688B-438D-9CDC-27D8A9DCAE4AQ38603222-0CF85FE2-87DC-4231-8EFF-E9996909EAFBQ38607538-E7FECCF2-1B29-43BA-B5E7-E59079820725Q38650931-A54C5822-4F24-4614-A37B-CC2C420847C4Q38729746-2E14B4D7-B3CF-4AAA-80EB-BDEE1F0798D8Q39035697-A7111493-27C8-4952-98CB-9B5396CCA4EEQ39251105-9D64ACA6-B950-4D0A-8949-133755BC24CAQ40293179-16EBB282-A0E6-489E-B91F-978750538EF3Q42753016-F86DB02F-04AF-4D51-ADB8-66C8E7A8086AQ43612808-170D89A6-810C-4357-A758-173BB21A8959Q44497798-343710F5-B0AA-4AB6-90E8-0F7ED540326CQ45384322-8B05F0C7-F8EE-4515-8022-B24AD338FA52Q45939575-1A4CDBF1-FAAB-4AA9-B4C9-AEF8E5EF0D57Q47289520-F97A55F7-4128-45B5-B66B-6CCE08ACFADDQ48133351-11B76202-9364-4E12-94B9-70708781864FQ48255876-D39C82D9-5E6A-4627-B7A9-5EEC414EE664Q48585140-007CD7C7-3273-424B-9966-EB1D30259729
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular risk after bariatric surgery for obesity
@en
Cardiovascular risk after bariatric surgery for obesity.
@nl
type
label
Cardiovascular risk after bariatric surgery for obesity
@en
Cardiovascular risk after bariatric surgery for obesity.
@nl
prefLabel
Cardiovascular risk after bariatric surgery for obesity
@en
Cardiovascular risk after bariatric surgery for obesity.
@nl
P2093
P2860
P921
P1476
Cardiovascular risk after bariatric surgery for obesity
@en
P2093
Abel Romero-Corral
Francisco Lopez-Jimenez
John A Batsis
Maria L Collazo-Clavell
Michael G Sarr
Virend K Somers
P2860
P304
P356
10.1016/J.AMJCARD.2008.05.040
P407
P577
2008-07-17T00:00:00Z